Omeprazole 20mg Delayed-Release Capsules from Canada
These capsules contain omeprazole, a proton pump inhibitor used to treat gastroesophageal reflux disease (GERD) and reduce stomach acid. Classified under HTS 3004.90.92.60 as a mixed product put up in measured doses for therapeutic use primarily affecting the digestive system.
Duty Rate — Canada → United States
100%
Rate breakdown
9903.04.60100%Pharmaceuticals: patented pharma articles — 100% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Verify FDA registration and provide Certificate of Pharmaceutical Product (CPP) for approval
• Ensure accurate labeling of active ingredients, dosage, and expiry per 21 CFR 201
• Avoid misclassification by confirming it's not a veterinary product (heading 3004.20)